Medical Applications of Liposomes

Author: Lasic   D. D.;Papahadjopoulos   D.  

Publisher: Elsevier Science‎

Publication year: 1998

E-ISBN: 9780080536088

P-ISBN(Paperback): 9780444829177

P-ISBN(Hardback):  9780444829177

Subject: R979.1 anti - tumor, anti - cancer drug

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

The development of liposomes as a drug delivery system has fluctuated since its introduction in the late 1960's by A.D. Bangham. While academic research of liposomes as a model membrane system has always flourished, as the exponential growth of papers can testify, the application of these findings to medically useful products has gone through several crises. Following the original optimism in the 70's and early 80's, a period of severe skepticism ensued at the end of the 80's and beginning of the 90's, culminating in a moderate but real optimism in the mid 90's, as a result of a successful launch of the first products in the US and Europe.

In this collection of papers, the editors have gathered the most promising ideas, approaches, applications and commercial developments, thereby presenting an up-to-date compilation of the present status of the field. This includes such broad areas as anti-cancer chemotherapy immune stimulation and infectious diseases. Currently, the major areas of progress are in delivery of anti-fungal agents by conventional liposomes or lipid-based carriers and systemic anticancer therapy using long-circulating liposomes. The future applications as characterized by the direction of present day research is in specific targeting and delivery of informational molecules such as DNA plasmids (genes), antisense oligonucleotides or ribozymes. Other future developments may be in topical delivery, vaccination and in diagnostics.

Features of this book:

Chapter

Front Cover

pp.:  1 – 4

Copyright Page

pp.:  5 – 8

Foreword

pp.:  8 – 12

Contents

pp.:  12 – 16

Section III: Infectious diseases

pp.:  180 – 236

Section IV: Cancer therapy

pp.:  236 – 362

Section V: Gene therapy

pp.:  362 – 466

Section VI: Other applications

pp.:  466 – 560

Section VII: Industrial manufacturing and pre-clinical testing

pp.:  560 – 640

Section VIII: Clinical testing of liposome pharmaceuticals

pp.:  640 – 766

Section IX: Future prospects

pp.:  766 – 770

Appendix 1. List of abbreviations

pp.:  770 – 776

Appendix 2. Primary amino acids

pp.:  776 – 778

List of Contributors

pp.:  778 – 786

Subject Index

pp.:  786 – 796

The users who browse this book also browse